Search Results - "Clements, J.A"

103: The tumour–stroma niche of ovarian cancer in 3D by Loessner, D, Holzapfel, B.M, Baldwin, J, Rockstroh, A, Magdolen, V, Hutmacher, D.W, Clements, J.A

Get full text

Murine, but not human, ephrin-B2 can be efficiently cleaved by the serine protease kallikrein-4: Implications for xenograft models of human prostate cancer by Lisle, J.E., Mertens-Walker, I., Stephens, C.R., Stansfield, S.H., Clements, J.A., Herington, A.C., Stephenson, S.-A.

“…Ephrin-B2 is the sole physiologically-relevant ligand of the receptor tyrosine kinase EphB4, which is over-expressed in many epithelial cancers, including 66%…”
Get full text

523: Identification of kallikrein-related peptidase 7 degradome and transcriptome targets in ovarian cancer by Munasinghage Silva, L, Stoll, T, Stansfield, S, Stephens, C, Hastie, M, Irving-Rodgers, H, Dong, Y, Gorman, J, Clements, J.A

Get full text

113 Unravelling the Tumour-stroma Microenvironment of Late Stage Ovarian Cancer by Loessner, D, Baldwin, J, Rockstroh, A, Irving-Rodgers, H, Magdolen, V, Hutmacher, D.W, Clements, J.A

Get full text

The kallikrein-related peptidase family: Dysregulation and functions during cancer progression by Kryza, T., Silva, M.L., Loessner, D., Heuzé-Vourc'h, N., Clements, J.A.

“…Cancer is the second leading cause of death with 14 million new cases and 8.2 million cancer-related deaths worldwide in 2012. Despite the progress made in…”
Get full text

Constraints to counting bioluminescence producing cells by a commonly used transgene promoter and its implications for experimental design by Mosaad, E. O., Futrega, K., Seim, I., Gloss, B., Chambers, K. F., Clements, J. A., Doran, M. R.

“…It is routine to genetically modify cells to express fluorescent or bioluminescent reporter proteins to enable tracking or quantification of cells in vitro and…”
Get full text

Association Analysis of a Microsatellite Repeat in the TRIB1 Gene With Prostate Cancer Risk, Aggressiveness and Survival by Moya, Leire, Lai, John, Hoffman, Andrea, Srinivasan, Srilakshmi, Panchadsaram, Janaththani, Chambers, Suzanne, Clements, Judith A, Batra, Jyotsna

“…With an estimated 1.1 million men worldwide diagnosed with prostate cancer yearly, effective and more specific biomarkers for early diagnosis could lead to…”
Get full text

Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript by Kote-Jarai, Z., Amin Al Olama, A., Leongamornlert, D., Tymrakiewicz, M., Saunders, E., Guy, M., Giles, G. G., Severi, G., Southey, M., Hopper, J. L., Sit, K. C., Harris, J. M., Batra, J., Spurdle, A. B., Clements, J. A., Hamdy, F., Neal, D., Donovan, J., Muir, K., Pharoah, P. D. P., Chanock, S. J., Brown, N., Benlloch, S., Castro, E., Mahmud, N., O’Brien, L., Hall, A., Sawyer, E., Wilkinson, R., Easton, D. F., Eeles, R. A.

“…Genome-wide association studies (GWAS) have identified more than 30 prostate cancer (PrCa) susceptibility loci. One of these (rs2735839) is located close to a…”
Get full text

8 
Australian prostate cancer collaboration (APCC) bioresource by HORSFALL, D.J, CLEMENTS, J.A.

“…The Mission Statement of the APCC is ‘To reduce mortality and morbidity and improve the quality of life of men with prostate cancer by facilitating…”
Get full text

Determining Protease Substrates Within a Complex Protein Background Using the PROtein TOpography and Migration Analysis Platform (PROTOMAP) by Fuhrman-Luck, R A, Silva, L M, Hastie, M L, Gorman, J J, Clements, J A

“…The PROtein TOpography and Migration Analysis Platform (PROTOMAP) approach is a degradomics technique used to determine protease substrates within complex…”
Get more information

Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans by Clements, J A, Nimmo, W S, Grant, I S

“…The pharmacokinetics of ketamine in analgesic doses after intravenous, intramuscular, and oral administration was investigated in healthy volunteers. Plasma…”
Get more information

16 
Kallikrein 15 (KLK15) in prostate cancer: in silico analysis and single nucleotide polymorphism verification by KEDDA, M.A., SKEIE, L.M., SMITH, R.L.G., HIGGINS, M., SPURDLE, A.B., YAXLEY, J., STEGINGA, S., CLEMENTS, J.A.

“…Introduction:  Prostate cancer is the most common cancer in Caucasian men and there is strong evidence that kallikreins are part of an enzymatic cascade…”
Get full text

Surfactant apoprotein Mr = 26,000-36,000 enhances uptake of liposomes by type II cells by Wright, J.R., Wager, R.E., Hawgood, S., Dobbs, L., Clements, J.A.

“…The alveolar type II cell which synthesizes and secretes surfactant also plays a major role in the reuptake of surfactant lipids. In a recent in vivo study we…”
Get full text

Urinary levels of substance P and its metabolites are not increased in interstitial cystitis by Campbell, D.J., Tenis, N., Rosamilia, A., Clements, J.A., Dwyer, P.L.

“…Objectives To determine whether interstitial cystitis is associated with the increased release of substance P from the bladder wall into urine, by measuring…”
Get full text

Low Molecular Weight Human Pulmonary Surfactant Protein (SP5): Isolation, Characterization, and cDNA and Amino Acid Sequences by Warr, Rhonda G., Hawgood, Samuel, Buckley, Douglas I., Crisp, Tracey M., Schilling, James, Benson, Bradley J., Ballard, Philip L., Clements, John A., White, R. Tyler

“…Pulmonary surfactant is a lipid-protein complex that promotes alveolar stability by lowering the surface tension at the air-fluid interface in the peripheral…”
Get full text

The Effect of Estrogen Replacement Therapy on CYP3A Activity by Haehner‐Daniels, B.D., Gorski, J.C., Carven, R., Wrighton, S.A., Clements, J.A., Bruce, M.A., Hall, S.D.

“…Clinical Pharmacology & Therapeutics (1999) 65, 192–192; doi:…”
Get full text

Inactive free : total prostate specific antigen ratios in ejaculate from men with suspected and known prostate cancer, compared with young control men by Clements, J.A., Merritt, T., DeVoss, K., Swanson, C., Hamlyn, L., Scells, B., Rohde, P., Lavin, M.F., Yaxley, J., Gardiner, R.A.

“…Objective To measure free : total prostate specific antigen (PSA) ratios in ejaculate from men with suspected and known prostate cancer, and in young control…”
Get full text

Re: Malignant cytological washings from radical prostatectomy specimens: a possible mechanism for local recurrence of prostate cancer following surgical treatment of organ confined disease by Gardiner, R A, Samaratunga, M L, Rohde, P, Clements, J A, Hyland, V, Lavin, M F

Get more information

Rapid and specific lowering of pituitary FSH beta mRNA levels by inhibin by Mercer, J E, Clements, J A, Funder, J W, Clarke, I J

“…Hypothalamo-pituitary disconnected sheep were given gonadotropin releasing hormone pulses every 2 h for 1 week, and the effects of inhibin on mRNA for FSH…”
Get more information

Treatment of penetrating abdominal wound by Clements, J.A.

Get full text